Basic information Safety Related Supplier

ChemicalBook Product Catalog Analytical Chemistry Standard Pharmaceutical Impurity Reference Standards Articaine hydrochloride

1/1

Articaine hydrochloride NEW

$31.00 25mg

$48.00 50mg

$77.00 100mg

Min. Order
Purity99.88%
Cas No23964-57-0
Supply Ability10g
Update time2024-11-19

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

5YR

United States

show more

Chemical Properties

Product Name	Articaine hydrochloride
CAS No	23964-57-0
EC-No
Min. Order
Purity	99.88%
Supply Ability	10g
Release date	2024/11/19

Product Introduction

Bioactivity

Name	Articaine hydrochloride
Description	Articaine hydrochloride (Hoe-045), a thiophene-containing local anesthetic, is pharmacologically similar to mepivacaine.
In vivo	The time to maximum drug concentrations of articaine occurs about 10 to 15 minutes after submucosal injection of articaine 4% 80 mg. The elimination half-time of articaine is about 20 minutes. Articaine is better able to diffuse through soft tissue and bone than other local anaesthetics, the concentration of articaine in the alveolus of a tooth in the upper jaw after extraction is about 100 times higher than that in systemic circulation. [1] Articaine: VAS (Visual Analogue Scale) scores (from 0 to 10 cm) by patients 4 to < 13 years of age are 0.5 for simple procedures and 1.1 for complex procedures, and average investigator scores are 0.4 and 0.6 for simple and complex procedures, respectively. No serious adverse events related to the articaine occurres, the only adverse event considered related to articaine is accidental lip injury in one patient. [2] Articaine results in success rate of 64.5% in electronic pulp testing in healthy adult volunteers injected with 4% articaine. Articaine infiltration produces significantly more episodes of no response to maximum stimulation in first molars than lidocaine. Mandibular buccal infiltration is more effective with 4% articaine with epinephrine compared to 2% lidocaine with epinephrine. [3] Articaine (4%) results in the success rate of 24% for the inferior alveolar nerve block in randomized, double-blind study. [4] Articaine formulation results in successful pulpal anesthesia ranged from 75 to 92 percent and onset of pulpal anesthesia ranged from 4.2 to 4.7 minutes in healthy volunteer. For articaine, 4 percent (two of 56) of the subjects reported swelling and no subjects reported bruising. Ninety-eight percent (59 of 60) of the subjects had lip numbness with the articaine solution. [5]
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 60 mg/mL (187.01 mM) H2O : 59 mg/mL (183.9 mM) Ethanol : 60 mg/mL (187 mM)
Keywords	dental \| Articaine \| Articaine Hydrochloride \| NOD-like Receptor (NLR) \| Hoe 045 \| amide \| pain relief \| Hoe045 \| Sodium Channel \| inhibit \| Na channels \| kidney injury \| Nuclear factor-κB \| LPS \| NF-κB \| Na+ channels \| Articaine hydrochloride \| Nuclear factor-kappaB \| Inhibitor
Inhibitors Related	Phenytoin sodium \| Lidocaine hydrochloride \| L-Aspartic aicd sodium
Related Compound Libraries	Membrane Protein-targeted Compound Library \| Anti-Cancer Clinical Compound Library \| Drug Repurposing Compound Library \| FDA-Approved Drug Library \| Anti-Cancer Approved Drug Library \| Ion Channel Targeted Library

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book